News Search Results
Jan 09, 2026, 08:00 ET Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
LEXINGTON, Mass., Jan. 9, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced the closing
More news about: Curis, Inc.
Jan 09, 2026, 07:30 ET Avista Therapeutics Expands AI Gene Therapy Platform to Break Barriers in the Delivery of Genetic Medicines
avistatx.com) is a biotechnology company spun out of the University of Pittsburgh, and built on deep clinical, computational and gene therapy expertise, whose mission is to break
More news about: Avista Therapeutics
Jan 09, 2026, 07:00 ET Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies
CAMBRIDGE, Mass., Jan. 9, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology platforms, today announced that it has entered into a multi-target antibody
More news about: Nona Biosciences
Jan 09, 2026, 06:59 ET Soft Gaskets Market worth $5.56 billion by 2030 - Exclusive Report by MarketsandMarkets™
Hence, envelope gaskets provide the non-reactive, corrosion-resistant, and hygienic sealing surface needed in chemical processing, pharmaceuticals, biotechnology, food & beverage, and high-purity applications. The demand for these gaskets is growing rapidly in Asia, Europe, and North America. The global
More news about: MarketsandMarkets
Jan 08, 2026, 17:06 ET Hong Kong Tech Firms Win Big at CES 2026 with Frontier Tech Innovations to Draw Global Buyer Interest
and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland
More news about: Hong Kong Tech
Jan 08, 2026, 16:05 ET BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
Company's website for a limited time following the conference. About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based
More news about: BioMarin Pharmaceutical Inc.
Jan 08, 2026, 16:00 ET CREATE Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
Mass., Jan. 8, 2026 /PRNewswire/ -- CREATE Medicines, Inc. ("CREATE" or the "Company"), a clinical-stage biotechnology company pioneering in vivo CAR therapy, today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on
More news about: CREATE Medicines, Inc.
Jan 08, 2026, 14:00 ET Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jan 08, 2026, 13:31 ET Akadeum Life Sciences to Highlight How Microbubbles Enable Rapid Cell Therapy Manufacturing for Larger Patient Populations at Biotech Showcase 2026
About Biotech Showcase Biotech Showcase is a premier investor and partnering conference that connects private and micro- to mid-cap biotechnology companies with the global investment community and biopharma executives. The annual event provides a forum for emerging innovators to highlight
More news about: Akadeum Life Sciences
Jan 08, 2026, 13:05 ET Muna Therapeutics Awarded $1 Million Alzheimer's Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer's
COPENHAGEN, Denmark and BOSTON, Jan. 8, 2026 /PRNewswire/ -- Muna Therapeutics, a clinical-stage biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases, today announced it has been awarded a $1 million research
More news about: Muna Therapeutics
Jan 08, 2026, 12:11 ET ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM
to this mission and its proven track record continues to attract industry-leading innovators across oncology and biotechnology.Dr. Patel is a physician-scientist and biotechnology executive with over two decades of leadership experience spanning Genentech, Pfizer, Juno, Lyell, and eFFECTOR Therapeutics.
More news about: Elephas
Jan 08, 2026, 10:30 ET Genomic Biomarkers Market worth $50.31 billion by 2030 | MarketsandMarkets™
https://www.marketsandmarkets.com/requestsampleNew.asp?id=48860286By application, the pharmaceutical & biotechnology companies segment was the fastest-growing segmentPharmaceutical & biotechnology companies were the fastest-growing segment of the genomic biomarkers market by end users. These
More news about: MarketsandMarkets
Jan 08, 2026, 10:20 ET Cleanova Strengthens Filtration Portfolio with Strategic Acquisitions of Airflotek and TES-Clean Air Systems, Entering Ultra-Clean Controlled Environment Markets
cleanroom environments worldwide, serving industries with exceptionally stringent air-quality requirements, including semiconductor manufacturing, biotechnology, and pharmaceuticals. Founded in 1986, TES-Clean Air Systems is the exclusive distributor of Airflotek products and brings decades of cleanroom
More news about: Cleanova
Jan 08, 2026, 10:20 ET Cleanova Strengthens Filtration Portfolio with Strategic Acquisitions of Airflotek and TES-Clean Air Systems, Entering Ultra-Clean Controlled Environment Markets
cleanroom environments worldwide, serving industries with exceptionally stringent air-quality requirements, including semiconductor manufacturing, biotechnology, and pharmaceuticals. Founded in 1986, TES-Clean Air Systems is the exclusive distributor of Airflotek products and brings decades of cleanroom
More news about: Cleanova
Jan 08, 2026, 10:00 ET CORCORAN ANNOUNCES NEW FRANCHISEE IN VIRGINIA WITH LAUNCH OF CORCORAN WILEY
began brokering real estate in 2005, following an extensive career as a Congressional staffer and working as a lobbyist for venture capital and biotechnology industries in both Boston and Washington, D.C. Following his collegiate studies, Justin Wiley honed his skillset through the management and advisory
More news about: The Corcoran Group
Jan 08, 2026, 09:00 ET Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity
TÜBINGEN, Germany, Jan. 8, 2026 /PRNewswire/ -- Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR
More news about: Acousia Therapeutics GmbH
Jan 08, 2026, 08:50 ET Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies for Patients
SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical‑stage biotechnology company pioneering autologous regenerative therapies, today announced completion of Cohort Three* dosing in the company's ASPIRO Phase 1/2a trial
More news about: Aspen Neuroscience, Inc.
Jan 08, 2026, 08:45 ET World-Renowned Alzheimer's Expert Prof. Steven Arnold Joins NeuroSense SAB
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that Prof. Steven E. Arnold, a world-renowned Alzheimer's
More news about: NeuroSense
Jan 08, 2026, 08:38 ET Mercury Bio Launches MB-TIP™--Revolutionizing Immunotherapy with Intracellular Targeting
Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP™ (Mercury
More news about: Mercury Bio Inc.
Jan 08, 2026, 08:31 ET Arkstone Taps Ian Campbell as CEO to Lead Next Phase of Growth and Innovation
M&ARALEIGH, N.C., Jan. 8, 2026 /PRNewswire/ -- Arkstone Medical Solutions, a biotechnology company transforming Clinical Decision Support (CDS) through "Expert-in-the-Loop" machine learning (ML) and artificial intelligence (AI), today
More news about: Arkstone
Jan 08, 2026, 08:30 ET Detecting and Characterizing RNA Drug Candidates to Accelerate Therapeutic Development, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Jan 08, 2026, 08:30 ET Veeva and BioMarin Form Long-Term Strategic Partnership
important new medicines and reach even more patients around the world."About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company
More news about: Veeva Systems
Jan 08, 2026, 08:30 ET Veeva and BioMarin Form Long-Term Strategic Partnership
important new medicines and reach even more patients around the world."About BioMarinBioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company
More news about: Veeva Systems
Jan 08, 2026, 08:00 ET Flagship Pioneering Appoints Adrian Rawcliffe as CEO-Partner and CEO of Etiome
pioneering new therapeutic approaches position him well to accelerate Etiome's mission to pioneer preemptive healthcare."Rawcliffe is a seasoned biotechnology leader with more than two decades of experience steering high-growth organizations through scientific, strategic, and financial inflection points.
More news about: Flagship Pioneering
Jan 08, 2026, 08:00 ET Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere
benchling.com/biotech-ai-report-2026.About BenchlingBenchling's mission is to unlock the power of biotechnology. Founded in 2012, Benchling provides a unified, cloud-based platform trusted by more than 1,300 biotech companies worldwide, from pioneering startups
More news about: Benchling